Christoph Schukro , 1 , David Santer 2 , Günther Prenner 3 , Markus Stühlinger 4 , Martin Martinek 5 , Alexander Teubl 6 , Deddo Moertl 7 , Stefan Schwarz 8 , Michael Nürnberg 9 , Lukas Fiedler 6 , Robert Hatala 10 , Cesar Khazen 11
14 August 2020
Within the last decade, implantable cardioverter‐defibrillator (ICD) systems with non‐transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non‐transvenous ICD systems, and provides specific recommendations for implantation, follow‐up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.